Townsquare Capital LLC Biomarin Pharmaceutical Inc Transaction History

Townsquare Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $136,727 - $169,408	1,837 Added 40.76%	6,344 $522,000
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $2,346 - $2,772	-28 Reduced 0.62%	4,507 $393,000
Q4 2023 Feb 15, 2024	SELL	$76.22 - $98.51 $16,387 - $21,179	-215 Reduced 4.53%	4,535 $437,000
Q3 2023 Nov 15, 2023	BUY	$85.07 - $94.48 $404,082 - $448,780	4,750 New	4,750 $420,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.